Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer

Completed · Not applicable

Conditions studied: Lung Cancer

In brief

RATIONALE: Using new methods to examine sputum samples for the presence of cancer cells may detect lung cancer earlier. PURPOSE: Screening trial to study the effectiveness of new methods of examining sputum samples to detect second primary lung cancer in patients with resected stage I non-small cell lung cancer.

Key facts

Study ID

NCT00002667

Run by

Eastern Cooperative Oncology Group

People needed

1100

Starts

1995-10-10

Expected to finish

2004-10-01

Last updated by the study team

2023-06-22

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
• CCOP - Northern New Jersey — Hackensack, New Jersey, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• Allegheny University Hospitals- Hahnemann — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.